{"id":560799,"date":"2026-08-10T21:57:33","date_gmt":"2026-08-10T19:57:33","guid":{"rendered":"https:\/\/medizinonline.com\/?p=560799"},"modified":"2026-08-10T21:57:43","modified_gmt":"2026-08-10T19:57:43","slug":"a-revolucao-das-incretinas-na-cardiologia","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/a-revolucao-das-incretinas-na-cardiologia\/","title":{"rendered":"A revolu\u00e7\u00e3o das incretinas na cardiologia"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>No espa\u00e7o de uma d\u00e9cada, os mim\u00e9ticos das incretinas passaram de medicamentos hipoglicemiantes para a diabetes a uma das classes de princ\u00edpios ativos mais din\u00e2micas da medicina cardiovascular. Os agonistas do recetor do GLP-1 (GLP-1-RA) demonstram, comprovadamente, reduzir o risco de eventos cardiovasculares graves (MACE) e de hospitaliza\u00e7\u00f5es por insufici\u00eancia card\u00edaca, diminuem a albumin\u00faria e retardam a diminui\u00e7\u00e3o da eGFR \u2014 e, cada vez mais, tamb\u00e9m fora do contexto da diabetes. Com o semaglutido oral, surge pela primeira vez um medicamento administrado por via oral com benef\u00edcios cardiovasculares comprovados, acompanhado da primeira grande base de dados sobre insufici\u00eancia card\u00edaca na diabetes tipo 2. E j\u00e1 se vislumbra no horizonte a pr\u00f3xima gera\u00e7\u00e3o, com os agonistas triplos, como o retatrutido.     <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fa-revolucao-das-incretinas-na-cardiologia%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>No espa\u00e7o de uma d\u00e9cada, os mim\u00e9ticos das incretinas passaram de medicamentos hipoglicemiantes para a diabetes a uma das classes de princ\u00edpios ativos mais din\u00e2micas da medicina cardiovascular. Os agonistas&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fa-revolucao-das-incretinas-na-cardiologia%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":560800,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"De medicamento antidiab\u00e9tico a uma classe terap\u00eautica cardiorrenal aut\u00f3noma","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11551,11367,11397,11521,11524,11426],"tags":[36497,95541,95539,17379,95540],"powerkit_post_featured":[],"class_list":["post-560799","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-pt","category-cardiologia-pt-pt","category-endocrinologia-e-diabetologia-2","category-estudos","category-formacao-continua","category-nefrologia-pt-pt","tag-antidiabeticos","tag-cimeira","tag-incretina","tag-semaglutidea","tag-sustain-6","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-08-21 20:28:11","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":560802,"slug":"la-revolucion-de-las-incretinas-en-la-cardiologia","post_title":"La revoluci\u00f3n de las incretinas en la cardiolog\u00eda","href":"https:\/\/medizinonline.com\/es\/la-revolucion-de-las-incretinas-en-la-cardiologia\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/560799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=560799"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/560799\/revisions"}],"predecessor-version":[{"id":560801,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/560799\/revisions\/560801"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/560800"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=560799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=560799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=560799"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=560799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}